Allergic diseases at the beginning of XXI century

Karina Jahnz-Różyk

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Contact Instructions for authors

2/2007
vol. 10

Send email

Copy url:

abstract:

Allergic diseases at the beginning of XXI century

Karina Jahnz-Różyk

Przew Lek 2007; 2: 155-159

Online publish date: 2007/03/16

View full text Get citation

The prevalence of allergic diseases is still increasing. However, the progress in pathomechanism, diagnosis and treatment of allergic diseases is observed. The mechanism of cross-reactive reactions in pollen-food syndrome was presented in this study. Additionally, new diagnostic method – microarray using recombinant allergens to detect allergen-specific serum immunoglobulin E was described. The recombinant allergens can be used to formulate optimal preparations for both diagnostic applications and specific casual immunotherapy. Recombinant DNA technology provides the possibility to create therapeutic vaccines containing only relevant allergic proteins. The progress in practical consideration and future of allergen specific immunotherapy were evaluated in this study. Moreover, clinical application of anti-IgE recombinant humanized monoclonal antibody for the treatment of severe and difficult allergic asthma was presented.

keywords:

Allergic diseases at the beginning of XXI century

Karina Jahnz-Różyk

allergic diseases, progress, diagnosis, treatment